Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dupilumab maintenance in atopic dermatitis
NCT02395133Phase 3Completed
- Sponsor
- Regeneron Pharmaceuticals
- Start
- Mar 2015
- Primary completion
- Jul 2016
- Modality
- Monoclonal Antibodies
01
Overview
A Phase 3 trial of dupilumab in atopic dermatitis (AD), sponsored by Regeneron Pharmaceuticals. Started Mar 2015; status: completed.
02
Drugs
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on NCT02395133.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02395133.